Benefit-risk balance for marketed drugs: evaluating safety signals

Benefit-risk balance for marketed drugs: evaluating safety signals

Guardat en:

Dades bibliogràfiques
Autor corporatiu:	Council for International Organizations of Medical Sciences (CIOMS)
Format:	Llibre
Idioma:	English
Publicat:	Geneva Council for International Organizations of Medical Sciences (CIOMS) 1998
Matèries:	Drugs Pharmaceutic Preparations Pharmaceutical Products Preparations, Pharmaceutical
Accés en línia:	Visit NHRC Library
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars

Martindale: the complete drug reference
per: Parfitt, Kathleen
Publicat: (1999)

WHO drug information.
Publicat: (2000)

WHO expert committee on specifications for pharmaceutical preparations
Publicat: (2006)

International nonproprietary names (INN) for pharmaceutical substances : lists 1-65 of proposed INN and lists 1-31 of recommended INN : cumulative list no. 8 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques : listes 1-65 de DCI proposées et listes 1-31 de DCI recommandées : liste récapitulative no. 8.
Publicat: (1992)

WHO expert committee on specifications for pharmaceutical preparations
Publicat: (2011)

WHO Expert Committee on Specifications for Pharmaceutical Preparations
Publicat: (2012)

USP DI. Approved drug products and legal requirements.
Publicat: (1995)

Where there are no pharmacists : a guide to managing medicines for all health workers /
per: Andersson, Sarah
Publicat: (2010)

Managing drug supply : the selection, procurement, distribution, and use of pharmaceuticals. the selection, procurement, distribution, and use of pharmaceuticals.
Publicat: (1997)

Pharmacology : a patient-centered nursing process approach /
per: Kee, Joyce LeFever, et al.

Drug calculations : ratio and proportion problems for clinical practice /
per: Seltzer, Meta Brown, et al.

Effective drug regulation a multicountry study /
per: Ratanawijitrasin, Sauwakon
Publicat: (2002)

WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-eighth meeting report /

Preparation of hazardous waste inventory
per: DEVS Consult Nepal (P) Ltd.
Publicat: (2013)

Client satisfaction and quality of curative services for sick children in Nepal: further analysis of the 2015 Nepal Health Facility Survey: DHS further analysis reports No. 114.
per: Acharya,Kiran
Publicat: (2018)

Regulatory Situation of Herbal Medicines
Publicat: (1998)

A text book of pharmacognosy.
per: Raut, Bechan, et al.
Publicat: (2007)

Status of Ayurvedic Medicines Available in the Markets of Nepal
per: Adhikari, SM, et al.
Publicat: (2016)

The Selection and Use of Essential Medicines Reports of the WHO Expert Committee on the Selection and Use of Essential Medicines and the 3rd WHO Model list of essential medicines for children
Publicat: (2012)

AHFS drug information 2000
per: Snow, Elaine, K
Publicat: (2000)

Safety requirements for the first use of new drugs and diagnostic agents in man : a review of safety issues in early clinical trials of drugs.
Publicat: (1983)

Final Report on Development of Profile of Toxic Waste Products in Nepal
per: Nepal Health Research Council (NHRC), et al.
Publicat: (2013)

Serotyping and antibiotic resistance profile of common bacterial isolates causing gastroenteritis.
per: Yadav, Raju
Publicat: (2016)

Ensuring balance in national policies on control substances: Guidelines for availability and accessibility of controlled medicines
Publicat: (2011)

Clinical trials: study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines
per: Brody, Tom
Publicat: (2016)

Evaluation of certain veterinary drug residues in food
Publicat: (2000)

WHO Expert Committee on biological standardization sixty-fourth meeting report /

Study on the Projection and Management of Health Care Professionals for the Next Ten Years
per: Aryal, BK, et al.
Publicat: (2016)

Impact of educational intervention on knowledge and practice of safety precaution of cytotoxic drugs administration among nurse.
per: Pande, Sarala
Publicat: (2011)

Status of Ayurvedic medicines available in the markets of Nepal
per: Adhikari, Shyam Mani
Publicat: (2008)

Status of Ayurvedic Medicines Available in the Markets of Nepal
per: Adhikari, Shyam Mani, Dr.
Publicat: (2012)

Evaluation of certain veterinary drug residues in food: Forty- second report of the joint FAO/WHO expert committee on food additives
Publicat: (1995)

Fundamentals of Clinical Trials /
per: Friedman, Lawrence M, et al.
Publicat: (2015)

Evaluation of certain veterinary drug residues in food : seventy-fifth[75th] report of the Joint FAO/WHO Expert Committee on Food Additives
Publicat: (2012)

The use of essential drugs : ninth report of the WHO Expert Committee (including the revised Model list of essential drugs).
Publicat: (2000)

Drug policy in the Americas
per: Smith, Peter H.
Publicat: (1992)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
Publicat: (2011)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
Publicat: (2011)

Iodized salt social marketing campaign (ISMAC): Baseline Study
per: Poudel, Krishna Prasad
Publicat: (2015)

Public Health Care Expenditures in Nepal: Review, Analysis and Assessment
per: Maskay, NM, et al.
Publicat: (2016)